Related Experiment Video

Updated: Aug 13, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Hypoglycemia in childhood: long-term effects

Christina Flykanaka-Gantenbein1

  • 1Unit of Endocrinology, Diabetes and Metabolism, 1st Department of Pediatrics, University of Athens, School of Medicine, Agia Sophia Children's Hospital, Thivon and Livadias, Goudi, Athens, Greece. ganten@hol.gr

Pediatric Endocrinology Reviews : PER
|January 31, 2006
PubMed

Insights

Severe hypoglycemia in early life can cause lasting brain damage and cognitive issues. Prompt management and prevention are crucial for children

Area of Science:

  • Neuroscience
  • Pediatrics
  • Endocrinology

Background:

  • Glucose is the primary fuel for the brain.
  • Inadequate glucose supply during development can cause severe neurological deficits.
  • Recurrent hypoglycemia in infancy is often linked to hyperinsulinism.

Purpose of the Study:

  • To highlight the severe neurological consequences of recurrent hypoglycemia in developing brains.
  • To discuss the link between hypoglycemia, neurocognitive dysfunction, and diabetes mellitus.
  • To emphasize the importance of timely management and prevention of hypoglycemia in children.

Main Methods:

  • This study is a review of existing literature on hypoglycemia and its effects.
  • It synthesizes findings on neurological impairments resulting from neonatal and infantile hypoglycemia.
  • It examines the impact of hypoglycemia on cognitive function and memory in diabetic children.

Main Results:

  • Neonatal hypoglycemia can lead to neurocognitive dysfunction, epilepsy, and developmental delays.
  • Infantile hyperinsulinism-related hypoglycemia is associated with cognitive issues and future diabetes.
  • Hypoglycemia in diabetic children can cause memory deficits and unawareness, increasing risks.

Conclusions:

  • Prompt and meticulous management of hypoglycemia is essential for preventing long-term neurological sequelae.
  • Prevention strategies are critical for ensuring a good quality of life for affected children.
  • Physicians must prioritize hypoglycemia management in neonatal, infant, and childhood care.

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.